UBXN2B
UBX domain-containing protein 2B
Also known as: p37, UBX2B_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14CS0
- Gene
- UBXN2B
- Ensembl
- ENSG00000215114
- Chromosome
- 8
- Canonical length
- 331 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable ubiquitin binding activity. Involved in establishment of mitotic spindle orientation; negative regulation of protein localization to centrosome; and positive regulation of mitotic centrosome separation. Predicted to be located in Golgi apparatus; endoplasmic reticulum; and spindle pole centrosome. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
331 residues, UniProt reviewed canonical sequence.
>Q14CS0|UBXN2B
1 MAEGGGPEPG EQERRSSGPR PPSARDLQLA LAELYEDEVK CKSSKSNRPK ATVFKSPRTP
61 PQRFYSSEHE YSGLNIVRPS TGKIVNELFK EAREHGAVPL NEATRASGDD KSKSFTGGGY
121 RLGSSFCKRS EYIYGENQLQ DVQILLKLWS NGFSLDDGEL RPYNEPTNAQ FLESVKRGEI
181 PLELQRLVHG GQVNLDMEDH QDQEYIKPRL RFKAFSGEGQ KLGSLTPEIV STPSSPEEED
241 KSILNAVVLI DDSVPTTKIQ IRLADGSRLI QRFNSTHRIL DVRNFIVQSR PEFAALDFIL
301 VTSFPNKELT DESLTLLEAD ILNTVLLQQL KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBXN2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- liver: 18 nTPM
- cerebellum: 17 nTPM
- parathyroid gland: 15 nTPM
- kidney: 15 nTPM
- bone marrow: 15 nTPM
- cerebral cortex: 14 nTPM
Single-cell type
- neutrophils: 908 nCPM
- neutrophil progenitors: 146 nCPM
- late spermatids: 100 nCPM
- monocytes: 89 nCPM
- lactotrophs: 71 nCPM
- microglia: 68 nCPM
Immune cell
- neutrophil: 43 nTPM
- eosinophil: 18 nTPM
- basophil: 16 nTPM
- non-classical monocyte: 13 nTPM
- classical monocyte: 12 nTPM
- intermediate monocyte: 11 nTPM
Brain region
- cerebellum: 33 nTPM
- white matter: 31 nTPM
- cerebral cortex: 28 nTPM
- hippocampal formation: 27 nTPM
- medulla oblongata: 27 nTPM
- basal ganglia: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0.1
- gnomAD missense Z
- 0.27
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome assembly
- establishment of mitotic spindle orientation
- Golgi organization
- membrane fusion
- negative regulation of protein localization to centrosome
- nuclear membrane reassembly
- positive regulation of mitotic centrosome separation
- proteasome-mediated ubiquitin-dependent protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBXN2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBXN2B as an antibody target. Whether an autoantibody or antibody against UBXN2B could matter depends on whether native UBXN2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBXN2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBXN2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...